S. McNitt

发表

QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

A. Moss, W. Zareba, M. Haigney, 2004, Journal of the American College of Cardiology.

Gender differences and risk of ventricular tachycardia or ventricular fibrillation.

A. Moss, W. Zareba, M. Haigney, 2009, Heart rhythm.

In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.

Jørgen K. Kanters, A. Moss, W. Zareba, 2012, Journal of the American College of Cardiology.

Predictive Value of Beat-to-Beat QT Variability Index Across the Continuum of Left Ventricular Dysfunction: Competing Risks of Noncardiac or Cardiovascular Death and Sudden or Nonsudden Cardiac Death

R. Berger, W. Zareba, A. Bayés‐Genís, 2012, Circulation. Arrhythmia and electrophysiology.

Convergence of models of human ventricular myocyte electrophysiology after global optimization to recapitulate clinical long QT phenotypes.

Stefan A. Mann, W. Zareba, J. Couderc, 2016, Journal of molecular and cellular cardiology.

Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics: MADIT-II substudy

W. Zareba, J. Couderc, S. Kääb, 2017, European heart journal.

Highly Automated QT Measurement Techniques in 7 Thorough QT Studies Implemented under ICH E14 Guidelines

C. Garnett, W. Zareba, J. Couderc, 2011, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy.

M. Link, H. Calkins, A. Moss, 2015, European heart journal.

Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.

H. Uno, S. Solomon, M. Pfeffer, 2011, European heart journal.

Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome.

Michael J Ackerman, Li Zhang, Wojciech Zareba, 2006, JAMA.

Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene

Bba, E. Kaufman, A. Moss, 2007, Circulation.

Long-QT Syndrome After Age 40

Derick R. Peterson, E. Kaufman, S. Priori, 2008, Circulation.

Genotype-phenotype aspects of type 2 long QT syndrome.

Michael J Ackerman, Wojciech Zareba, Wataru Shimizu, 2009, Journal of the American College of Cardiology.

Trigger-specific risk factors and response to therapy in long QT syndrome type 2.

E. Kaufman, A. Moss, J. Towbin, 2010, Heart rhythm.

Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.

Michael J Ackerman, Wojciech Zareba, Wataru Shimizu, 2011, Heart rhythm.

Trigger-specific ion-channel mechanisms, risk factors, and response to therapy in type 1 long QT syndrome.

E. Kaufman, A. Moss, J. Towbin, 2012, Heart rhythm.

Clinical Course and Risk Stratification of Patients Affected with the Jervell and Lange‐Nielsen Syndrome

A. Moss, J. Towbin, W. Zareba, 2006, Journal of cardiovascular electrophysiology.

Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

A. Moss, W. Zareba, J. Daubert, 2004, Circulation.

Smoking and the Risk of Stroke in Patients with a Left Ventricular Assist device

Leway Chen, I. Goldenberg, S. McNitt, 2021, ASAIO journal.

Implantation of a fully magnetically levitated left ventricular assist device using a sternal-sparing surgical technique.

S. Prasad, I. Goldenberg, Peter A. Knight, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Clinical Significance of Early Hospital Readmission in Continuous-Flow Left Ventricular Assist Device Patients

S. McNitt, S. Sherazi, V. Kutyifa, 2019, ASAIO journal.

Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist Devices.

R. Strawderman, W. Zareba, Leway Chen, 2017, The American journal of cardiology.

Use of Mutant-Specific Ion Channel Characteristics for Risk Stratification of Long QT Syndrome Patients

Matthias Reumann, Wojciech Zareba, Wataru Shimizu, 2011, Science Translational Medicine.

Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.

Wojciech Zareba, Ollivier Hyrien, Jean-Philippe Couderc, 2008, Drug safety.

Effect of a Multidisciplinary Pulmonary Embolism Response Team on Patient Mortality

I. Goldenberg, Ayman Elbadawi, Nicole M. Acquisto, 2021, The American Journal of Cardiology.

Predictive Capability of Left Atrial Size Measured by CT, TEE, and TTE for Recurrence of Atrial Fibrillation Following Radiofrequency Catheter Ablation

Burr Hall, Karl Q Schwarz, Christian Jons, 2010, Pacing and clinical electrophysiology : PACE.

Reduction in inappropriate therapy and mortality through ICD programming.

Wojciech Zareba, Arthur J Moss, Brian Olshansky, 2012, The New England journal of medicine.

Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.

H. Calkins, D. Bluemke, J. Towbin, 2009, Heart rhythm.

Prognostic Usefulness of Systolic Blood Pressure One-Year Following Cardiac Resynchronization Therapy (from MADIT-CRT).

W. Zareba, I. Goldenberg, S. McNitt, 2019, The American journal of cardiology.

Long‐term outcomes of cardiac resynchronization therapy by left ventricular ejection fraction

S. Solomon, A. Moss, S. McNitt, 2018, European journal of heart failure.

Left Ventricular Reverse Remodeling in Cardiac Resynchronization Therapy and Long-Term Outcomes.

S. Solomon, T. Biering-Sørensen, W. Zareba, 2019, JACC. Clinical electrophysiology.

Predictors of long‐term mortality with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block

S. Solomon, W. Zareba, I. Goldenberg, 2018, Clinical cardiology.

Baseline adverse electrical remodeling and the risk for ventricular arrhythmia in Cardiac Resynchronization Therapy Recipients (MADIT CRT)

A. Moss, W. Zareba, J. Couderc, 2016, Journal of cardiovascular electrophysiology.

Right ventricular lead location, right-left ventricular lead interaction, and long-term outcomes in cardiac resynchronization therapy patients

A. Moss, W. Zareba, H. Klein, 2018, Journal of Interventional Cardiac Electrophysiology.

Comparison of Long-Term Survival Benefits With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Versus Without Diabetes Mellitus (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]).

A. Moss, I. Goldenberg, H. Klein, 2018, The American journal of cardiology.

Multiple Comorbidities and Response to Cardiac Resynchronization Therapy: MADIT-CRT Long-Term Follow-Up.

S. Solomon, A. Moss, W. Zareba, 2017, Journal of the American College of Cardiology.

Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney disease

Paul J. Wang, S. Solomon, A. Moss, 2017, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Effect of Significant Weight Change on Inappropriate Implantable Cardioverter‐Defibrillator Therapy

Paul J. Wang, A. Moss, W. Zareba, 2017, Pacing and clinical electrophysiology : PACE.

Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch BlockCLINICAL PERSPECTIVE

A. Moss, W. Zareba, I. Cygankiewicz, 2016 .

Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.

A. Moss, W. Zareba, I. Cygankiewicz, 2016, Circulation. Heart failure.

Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.

S. Solomon, T. Biering-Sørensen, A. Moss, 2016, Cardiology journal.

Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.

Andy Y Lee, A. Moss, W. Zareba, 2015, Heart rhythm.

Effect of Cardiac Resynchronization Therapy in Patients With Insulin-Treated Diabetes Mellitus.

S. Solomon, A. Moss, W. Zareba, 2015, The American journal of cardiology.

in the MADIT-CRT trial

Andy Y Lee, A. Moss, W. Zareba, 2015 .

Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).

Andy Y Lee, A. Moss, W. Zareba, 2015, The American journal of cardiology.

Early intervention and long‐term outcome with cardiac resynchronization therapy in patients without a history of advanced heart failure symptoms

Andy Y Lee, S. Solomon, A. Moss, 2015, European journal of heart failure.

Reduced risk of life‐threatening ventricular tachyarrhythmias with cardiac resynchronization therapy: relationship to left ventricular ejection fraction

S. Solomon, A. Moss, W. Zareba, 2015, European journal of heart failure.

Long-term outcome with cardiac resynchronization therapy in mild heart failure patients with left bundle branch block from US and Europe MADIT-CRT

S. Solomon, A. Moss, W. Zareba, 2015, Heart Failure Reviews.

Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction

S. Solomon, A. Moss, W. Zareba, 2015, Circulation. Heart failure.

Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.

A. Moss, W. Zareba, I. Goldenberg, 2015, Circulation. Heart failure.

Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients with Mild Heart Failure: A MADIT-CRT Long-Term Follow-Up Sub-Study

A. Moss, W. Zareba, I. Goldenberg, 2015 .

A metric for evaluating the cardiac response to resynchronization therapy.

S. Solomon, A. Moss, W. Zareba, 2014, The American journal of cardiology.

Survival with cardiac-resynchronization therapy in mild heart failure.

S. Solomon, M. Pfeffer, A. Moss, 2014, The New England journal of medicine.

QRS Axis and the Benefit of Cardiac Resynchronization Therapy in Patients with Mildly Symptomatic Heart Failure Enrolled in MADIT‐CRT

A. Moss, W. Zareba, D. Cannom, 2013, Journal of cardiovascular electrophysiology.

The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

S. Solomon, A. Moss, W. Zareba, 2013, Journal of the American College of Cardiology.

Cardiac Resynchronization The Influence of Left Ventricular Ejection Fraction on the Effectiveness of Cardiac Resynchronization Therapy MADIT-CRT ( Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy )

Wojciech Zareba, Arthur J. Moss, Axel Kloppe, 2013 .

Brain Natriuretic Peptide and Cardiac Resynchronization Therapy in Patients With Mildly Symptomatic Heart Failure

S. Solomon, A. Moss, W. Zareba, 2013, Circulation. Heart failure.

Baseline functional capacity and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.

A. Moss, W. Zareba, I. Goldenberg, 2012, Heart rhythm.

Methods Main Study Protocol and Treatment The protocol and results of the Multicenter Automatic Defibrillator Implantation Trial – Cardiac Resynchronization Therapy

S. Solomon, A. Moss, W. Zareba, 2022 .

Cardiac resynchronization therapy is associated with reductions in left atrial volume and inappropriate implantable cardioverter-defibrillator therapy in MADIT-CRT.

Paul J. Wang, S. Solomon, A. Moss, 2014, Heart rhythm.

Hospitalization for Heart Failure and Subsequent Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.

W. Zareba, I. Goldenberg, S. McNitt, 2021, JACC. Clinical electrophysiology.

Repolarization variability in the risk stratification of MADIT II patients.

Wojciech Zareba, Jean-Philippe Couderc, Arthur J Moss, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Utility of Cardiovascular Implantable Electronic Device-Derived Patient Activity to Predict Clinical Outcomes.

W. Zareba, I. Goldenberg, K. Stein, 2021, Heart rhythm.

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

Wojciech Zareba, Arthur J Moss, Scott McNitt, 2008, Journal of the American College of Cardiology.

Cardiac Resynchronization Therapy and Ventricular Tachyarrhythmia Burden.

W. Zareba, N. Bragazzi, I. Goldenberg, 2021, Heart rhythm.

Left Ventricular Lead Position and Clinical Outcome in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Trial

Wojciech Zareba, Arthur J Moss, David T Huang, 2011, Circulation.

Low Atrial Fibrillatory Rate Is Associated With Poor Outcome in Patients With Mild to Moderate Heart Failure

M. Stridh, W. Zareba, A. Bayés‐Genís, 2012, Circulation. Arrhythmia and electrophysiology.

Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators.

A. Moss, W. Zareba, I. Cygankiewicz, 2009, Heart rhythm.

Metabolic syndrome is associated with different clinical outcome after cardiac resynchronization therapy in patients with ischemic and non-ischemic cardiomyopathy.

A. Moss, W. Zareba, S. McNitt, 2016, Cardiology journal.

Relationship between age and inappropriate implantable cardioverter-defibrillator therapy in MADIT-RIT (Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy).

A. Moss, W. Zareba, I. Goldenberg, 2016, Heart rhythm.

Mechanisms of Ventricular Fibrillation Initiation in MADIT II Patients with Implantable Cardioverter Defibrillators

A. Moss, W. Zareba, J. Daubert, 2008, Pacing and clinical electrophysiology : PACE.

Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.

S. Solomon, A. Moss, W. Zareba, 2013, Heart rhythm.

Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.

A. Moss, W. Zareba, R. Krone, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

ECG Quantification of Myocardial Scar and Risk Stratification in MADIT‐II

D. Strauss, W. Zareba, J. Daubert, 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Efficacy of Medical Therapy for the Reduction of Heart Failure Events in Patients with Implanted Cardioverter Defibrillators

A. Moss, W. Zareba, I. Goldenberg, 2009, Journal of cardiovascular electrophysiology.

Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.

A. Moss, W. Zareba, J. Daubert, 2007, Heart rhythm.

Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II).

A. Moss, W. Zareba, J. Daubert, 2005, The American journal of cardiology.

The Clinical Implications of Cumulative Right Ventricular Pacing in the Multicenter Automatic Defibrillator Trial II

Paul J. Wang, A. Moss, W. Zareba, 2005, Journal of cardiovascular electrophysiology.

Frequency of Inappropriate Therapy in Patients Implanted with Dual‐ Versus Single‐Chamber ICD Devices in the ICD Arm of MADIT‐CRT

Paul J. Wang, A. Moss, W. Zareba, 2013, Journal of cardiovascular electrophysiology.

Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing.

J. Daubert, F. Morady, F. Pelosi, 2007, Cardiology journal.

Differences in Outcomes Between Patients Treated with Single‐ versus Dual‐Chamber Implantable Cardioverter Defibrillators: A Substudy of the Multicenter Automatic Defibrillator Implantation Trial II

A. Moss, W. Zareba, S. McNitt, 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Clinical Course and Implantable Cardioverter Defibrillator Therapy in Postinfarction Women with Severe Left Ventricular Dysfunction

J. Ruskin, A. Moss, W. Zareba, 2005, Journal of cardiovascular electrophysiology.

Temporal aspects of improved survival with the implanted defibrillator (MADIT-II).

A. Moss, W. Zareba, S. McNitt, 2004, The American journal of cardiology.

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)

W. Zareba, I. Goldenberg, S. McNitt, 2020, Heart rhythm O2.

Platelet Extracellular Regulated Protein Kinase 5 Is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion

J. Abe, S. McNitt, S. Cameron, 2015, Circulation.

Physical functioning and mental well-being in association with health outcome in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial II.

A. Moss, W. Zareba, K. Noyes, 2006, European heart journal.

Cardiac Resynchronization Therapy Reduces the Risk of Cardiac Events in Patients With Diabetes Enrolled in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)

M. Rutter, A. Moss, R. Nesto, 2011, Circulation. Heart failure.

Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).

Paul J. Wang, M. Link, S. Solomon, 2011, Journal of the American College of Cardiology.

Cardiac Resynchronization Therapy Cardiac Resynchronization Therapy Reduces Left Atrial Volume and the Risk of Atrial Tachyarrhythmias in MADIT-CRT ( Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy )

Paul J. Wang, M. Link, S. Solomon, 2011 .

Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.

A. Moss, W. Zareba, W. Shimizu, 2016, Heart rhythm.

Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trial.

Jagmeet P. Singh, Paul J. Wang, A. Moss, 2013, European heart journal.

Effect on cardiac function of cardiac resynchronization therapy in patients with right bundle branch block (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT] trial).

A. Moss, W. Zareba, H. Klein, 2013, The American journal of cardiology.

Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block

A. Moss, W. Zareba, I. Goldenberg, 2015, Journal of the American Heart Association.

Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.

A. Moss, W. Zareba, J. Daubert, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Circadian variation and seasonal distribution of implantable defibrillator detected new onset atrial fibrillation

W. Zareba, I. Goldenberg, S. McNitt, 2020, Pacing and clinical electrophysiology : PACE.

Relative Wall Thickness and the Risk for Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction.

S. Solomon, A. Moss, W. Zareba, 2016, Journal of the American College of Cardiology.

Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction.

A. Moss, W. Zareba, I. Goldenberg, 2006, The American journal of cardiology.

Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT‐CRT

S. Solomon, M. Pfeffer, A. Moss, 2014, European journal of heart failure.

Insulin resistance predicts the risk for recurrent coronary events in post-infarction patients.

A. Moss, W. Zareba, S. McNitt, 2015, Cardiology journal.

Effect of Elapsed Time From Coronary Revascularization to Implantation of a Cardioverter Defibrillator on Long‐Term Survival in the MADIT‐II Trial

A. Moss, W. Zareba, V. Guetta, 2011, Journal of cardiovascular electrophysiology.

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy

W. Zareba, I. Goldenberg, S. McNitt, 2021, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT)

Paul J. Wang, A. Moss, M. Emdin, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Postimplantation ventricular ectopic burden and clinical outcomes in cardiac resynchronization therapy‐defibrillator patients: a MADIT‐CRT substudy

A. Moss, W. Zareba, J. Daubert, 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up

A. Moss, W. Zareba, I. Goldenberg, 2016, Clinical Research in Cardiology.

QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II

A. Moss, W. Zareba, S. McNitt, 2012, Journal of cardiovascular electrophysiology.

Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).

A. Moss, W. Zareba, S. McNitt, 2013, Journal of the American College of Cardiology.

Reassessing the role of Antitachycardia Pacing in Fast Ventricular Arrhythmias in Primary Prevention Implantable Cardioverter Defibrillator Recipients: Results from MADIT-RIT.

W. Zareba, J. Daubert, C. Schuger, 2020, Heart rhythm.

Effectiveness of high rate and delayed detection ICD programming by race: A MADIT‐RIT substudy

Kevin L. Thomas, A. Moss, W. Zareba, 2018, Journal of cardiovascular electrophysiology.

Reduction in Inappropriate ICD Therapy in MADIT‐RIT Patients Without History of Atrial Tachyarrhythmia

A. Moss, W. Zareba, J. Daubert, 2015, Journal of cardiovascular electrophysiology.

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

J. Ruskin, A. Moss, W. Zareba, 2006, Journal of the American College of Cardiology.

Repolarization duration in patients with conduction disturbances after myocardial infarction.

A. Moss, W. Zareba, S. McNitt, 2007, The American journal of cardiology.

Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia events

A. Moss, W. Zareba, S. McNitt, 2016, Cardiovascular Diabetology.

Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.

A. Moss, W. Zareba, I. Goldenberg, 2010, American Journal of Cardiology.

Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial).

Abrar H. Shah, S. Solomon, A. Moss, 2014, The American journal of cardiology.

Mortality Reduction in Relation to Implantable Cardioverter Defibrillator Programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT)

A. Moss, M. Shoda, W. Zareba, 2014, Circulation. Arrhythmia and electrophysiology.

Mortality Reduction In Relation To ICD Programming In MADIT-RIT

A. Moss, M. Shoda, W. Zareba, 2014 .

The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Ther

Paul J. Wang, A. Moss, W. Zareba, 2014, Journal of the American College of Cardiology.

Long-Term Survival With Implantable Cardioverter-Defibrillator in Different Symptomatic Functional Classes of Heart Failure.

A. Moss, W. Zareba, I. Goldenberg, 2016, The American journal of cardiology.

Competing risk analysis of ventricular arrhythmia events in heart failure patients with moderately compromised renal dysfunction.

W. Zareba, S. McNitt, M. Aktas, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT).

S. Solomon, M. Pfeffer, A. Moss, 2010, Heart rhythm.

Mutations in Conserved Amino Acids in the KCNQ1 Channel and Risk of Cardiac Events in Type‐1 Long‐QT Syndrome

A. Moss, J. Towbin, W. Zareba, 2009, Journal of cardiovascular electrophysiology.

Circadian Distribution of Ventricular Tachyarrhythmias and Association with Mortality in the MADIT‐CRT Trial

A. Moss, W. Zareba, S. McNitt, 2015, Journal of cardiovascular electrophysiology.

Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator: An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II

A. Moss, W. Zareba, I. Cygankiewicz, 2010, Circulation.

CHA2DS2‐VASc Score and the Risk of Ventricular Tachyarrhythmic Events and Mortality in MADIT‐CRT

J. Goldberger, R. Beinart, I. Goldenberg, 2019, Journal of the American Heart Association.

A prospective, randomized trial of topical hemostasis patch use following percutaneous coronary and peripheral intervention.

W. Zareba, S. McNitt, C. Narins, 2008, The Journal of invasive cardiology.

Variability of Activated Clotting Time by Site of Sample Draw During Percutaneous Coronary Intervention: A Prospective Single-Center Study

I. Goldenberg, S. McNitt, C. Narins, 2021, Angiology.

Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life- Threatening Events: Implications for Mutation-Specific Response to Beta- Blocker Therapy in Type-1 Long QT Syndrome Running title: Barsheshet et al.; Mutations in Cytoplasmic Loops of KCNQ1 Channel

Derick R. Peterson, E. Kaufman, A. Moss, 2012 .

Right Ventricular Dysfunction and the Incidence of Implantable Cardioverter‐Defibrillator Therapies

W. Zareba, J. Daubert, Burr Hall, 2009, Pacing and clinical electrophysiology : PACE.

AnaLysIs of Both sex and device specific factoRs on outcomes in pAtients with non-ischemic cardiomyopathy (BIO-LIBRA): Design and clinical protocol

W. Zareba, S. McNitt, M. Gleva, 2020, Heart rhythm O2.

Marital Status and Long-Term Outcomes in Mild Heart Failure Patients With an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator.

W. Zareba, S. McNitt, M. Aktas, 2020, The American journal of cardiology.

Relation between resting heart rate and the risk of ventricular tachyarrhythmias in MADIT-RIT.

R. Beinart, I. Goldenberg, S. McNitt, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Predictors and Outcomes of Atrial Tachyarrhythmia among Patients with Implantable Defibrillators.

E. Heist, I. Goldenberg, S. McNitt, 2019, Heart rhythm.

Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.

Jagmeet P. Singh, S. Solomon, A. Moss, 2018, JACC. Clinical electrophysiology.

Heart failure severity, inappropriate ICD therapy, and novel ICD programming: a MADIT‐RIT substudy

A. Moss, W. Zareba, J. Daubert, 2017, Pacing and clinical electrophysiology : PACE.

Bipolar left ventricular pacing is associated with significant reduction in heart failure or death in CRT-D patients with LBBB.

Paul J. Wang, A. Moss, W. Zareba, 2016, Heart rhythm.

Time Dependence of Ventricular Tachyarrhythmias After Myocardial Infarction: A MADIT-CRT Substudy.

A. Moss, W. Zareba, I. Goldenberg, 2016, JACC. Clinical electrophysiology.

Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).

A. Moss, W. Zareba, S. McNitt, 2013, Journal of the American College of Cardiology.

Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.

S. Solomon, A. Moss, W. Zareba, 2011, Journal of the American College of Cardiology.

Risk Factors for Sudden Cardiac Death in Patients with Chronic Renal Insufficiency and Left Ventricular Dysfunction

A. Cheung, A. Moss, M. Chonchol, 2007, American Journal of Nephrology.

Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

A. Moss, W. Zareba, I. Goldenberg, 2007, Journal of the American College of Cardiology.

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD

W. Zareba, I. Goldenberg, S. McNitt, 2020, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Coronary Artery Disease Inverse Relationship of Blood Pressure Levels to Sudden Cardiac Mortality and Benefit of the Implantable Cardioverter-Defibrillator in Patients With Ischemic Left Ventricular Dysfunction

A. Moss, W. Zareba, I. Goldenberg, 2007 .

Polymorphism in the Angiotensinogen Gene, Hypertension, and Ethnic Differences in the Risk of Recurrent Coronary Events

A. Moss, W. Zareba, I. Goldenberg, 2006, Hypertension.

Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.

Michael J. Ackerman, Pyotr G. Platonov, Wojciech Zareba, 2011, Journal of the American College of Cardiology.

Risk Stratification of Type 2 Long-QT Syndrome Mutation Carriers With Normal QTc Interval: The Value of Sex, T-Wave Morphology, and Mutation Type

A. Moss, W. Zareba, P. Platonov, 2018, Circulation. Arrhythmia and electrophysiology.

Identification of Low‐Risk Adult Congenital LQTS Patients

A. Moss, W. Zareba, I. Goldenberg, 2015, Journal of cardiovascular electrophysiology.

Long‐QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder

E. Kaufman, A. Moss, W. Zareba, 2015, Journal of cardiovascular electrophysiology.

Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome.

E. Kaufman, A. Moss, J. Towbin, 2013, Heart rhythm.

Long-Term Survival of Patients With Left Bundle Branch Block Who Are Hypo-Responders to Cardiac Resynchronization Therapy.

S. Solomon, A. Moss, W. Zareba, 2017, The American journal of cardiology.

PR Interval Identifies Clinical Response in Patients With Non–Left Bundle Branch Block: A Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy Substudy

A. Moss, W. Zareba, J. Daubert, 2014, Circulation. Arrhythmia and electrophysiology.

Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.

S. Solomon, A. Moss, W. Zareba, 2013, Heart rhythm.

Clinical significance of ventricular tachyarrhythmias in patients treated with CRT-D.

Paul J. Wang, A. Moss, W. Zareba, 2013, Heart rhythm.

Effects of cardiac resynchronization therapy on left ventricular mass and wall thickness in mild heart failure patients in MADIT-CRT.

Paul J. Wang, S. Solomon, M. Pfeffer, 2013, Heart rhythm.

Dyssynchrony and the risk of ventricular arrhythmias.

Paul J. Wang, S. Solomon, A. Moss, 2013, JACC. Cardiovascular imaging.

Implantation Trial With Cardiac Resynchronization Therapy) Trial

S. Solomon, A. Moss, W. Zareba, 2011 .

Predicting effectiveness of cardiac resynchronization therapy based on QRS decomposition using the Meyer orthogonal wavelet transformation

W. Zareba, J. Couderc, S. McNitt, 2010, 2010 Computing in Cardiology.

Risk factors and outcomes associated with the development of myocardial ischemic events in patients who receive cardiac resynchronization therapy.

A. Moss, W. Zareba, I. Goldenberg, 2013, The American journal of cardiology.

The Burden and Morphology of Premature Ventricular Contractions and their Impact on Clinical Outcomes in Patients Receiving Biventricular Pacing in the Multicenter Automatic Defibrillator Implantation Trial‐Cardiac Resynchronization Therapy (MADIT‐CRT)

A. Moss, W. Zareba, S. McNitt, 2016, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Syncope in High-Risk Cardiomyopathy Patients with Implantable Defibrillators: Frequency, Risk Factors, Mechanisms and Association with Mortality: Results from the MADIT-RIT Study

A. Moss, M. Shoda, W. Zareba, 2013 .

Pharmacists as members of an interdisciplinary pulmonary embolism response team

I. Goldenberg, Christine M. Groth, Nicole M. Acquisto, 2021, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.

The common apolipoprotein A-1 polymorphism −75A>G is associated with ethnic differences in recurrent coronary events after recovery from an acute myocardial infarction

A. Moss, W. Zareba, G. Vorobiof, 2009, Heart international.

Association of Cardiac Resynchronization Therapy With Change in Left Ventricular Ejection Fraction in Patients With Chemotherapy-Induced Cardiomyopathy.

Jagmeet P. Singh, S. Solomon, W. Zareba, 2019, JAMA.

Polymorphisms in the paraoxonase and endothelial nitric oxide synthase genes and the risk of early-onset myocardial infarction.

G. Glazko, A. Moss, W. Zareba, 2007, The American journal of cardiology.

Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes.

Geoffrey C. Williams, J. Bisognano, S. McNitt, 2012, The American journal of cardiology.

Prognostic Importance of Defibrillator‐Appropriate Shocks and Antitachycardia Pacing in Patients With Mild Heart Failure

W. Zareba, I. Goldenberg, S. McNitt, 2019, Journal of the American Heart Association.

Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.

S. Solomon, A. Moss, W. Zareba, 2013, Heart rhythm.

Polymorphism in the Cholesteryl Ester Transfer Protein Gene and the Risk of Early Onset Myocardial Infarction among Cigarette Smokers

A. Moss, W. Zareba, I. Goldenberg, 2007, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.

Paul J. Wang, S. Solomon, A. Moss, 2015, European heart journal.

Obesity As a Risk Factor for Sustained Ventricular Tachyarrhythmias in MADIT II Patients

A. Moss, W. Zareba, I. Goldenberg, 2007, Journal of cardiovascular electrophysiology.

Long-term milrinone therapy as a bridge to heart transplantation: Safety, efficacy, and predictors of failure.

Leway Chen, I. Goldenberg, S. McNitt, 2020, International journal of cardiology.

Sex Differences in the Risk of First and Recurrent Ventricular Tachyarrhythmias Among Patients Receiving an Implantable Cardioverter-Defibrillator for Primary Prevention

W. Zareba, I. Goldenberg, H. Klein, 2022, JAMA network open.

Effectiveness of Implantable Cardioverter-Defibrillators to Reduce Mortality in Patients With Long QT Syndrome.

W. Zareba, C. Seplaki, D. Rich, 2021, Journal of the American College of Cardiology.

Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score.

W. Zareba, J. Daubert, J. Goldberger, 2021, European heart journal.

Survival After Implantable Cardioverter-Defibrillator Shocks.

W. Zareba, J. Daubert, I. Goldenberg, 2021, Journal of the American College of Cardiology.

Systolic Blood Pressure and Risk for Ventricular Arrhythmia in Patients with an Implantable Cardioverter Defibrillator.

R. Beinart, I. Goldenberg, S. McNitt, 2020, The American journal of cardiology.

Sex Differences in Inappropriate ICD Device Therapies: MADIT‐II and MADIT‐CRT

Paul J. Wang, A. Moss, W. Zareba, 2017, Journal of cardiovascular electrophysiology.

Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT‐RIT substudy

A. Moss, W. Zareba, P. Veazie, 2017, American heart journal.

Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT‐CRT) Trial

Paul J. Wang, A. Moss, W. Zareba, 2015, Journal of cardiovascular electrophysiology.

End‐of‐Life Care in Patients with Implantable Cardioverter Defibrillators: A MADIT‐II Substudy

Abrar H. Shah, A. Moss, W. Zareba, 2013, Pacing and clinical electrophysiology : PACE.

Prognostic value of location and type of myocardial infarction in the setting of advanced left ventricular dysfunction.

A. Moss, W. Zareba, S. McNitt, 2007, The American journal of cardiology.

Cigarette Smoking and the Risk of Supraventricular and Ventricular Tachyarrhythmias in High‐Risk Cardiac Patients with Implantable Cardioverter Defibrillators

A. Moss, W. Zareba, J. Daubert, 2006, Journal of cardiovascular electrophysiology.

Effectiveness of the implantable cardioverter defibrillator in blacks versus whites (from MADIT-II).

A. Moss, W. Zareba, G. Vorobiof, 2006, The American journal of cardiology.

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

A. Moss, W. Zareba, S. McNitt, 2005, The American journal of cardiology.

Smoking is associated with an increased risk of first and recurrent ventricular tachyarrhythmias in ischemic and nonischemic patients with mild heart failure: a MADIT-CRT substudy.

A. Moss, W. Zareba, I. Goldenberg, 2014, Heart rhythm.

Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.

M. Link, W. Zareba, N. Estes, 2014, Journal of the American College of Cardiology.

JT interval: What does this interval mean?

W. Zareba, J. Couderc, S. McNitt, 2017, Journal of electrocardiology.

Platelet ERK 5 is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion

J. Abe, S. McNitt, S. Cameron, 2015 .

Wojciech Zareba, Arthur J Moss, Scott McNitt, 2008, The American journal of cardiology.

Population-based beat-to-beat QT analysis from Holter recordings in the long QT syndrome.

W. Zareba, J. Couderc, S. McNitt, 2017, Journal of electrocardiology.

Sex Hormones and Repolarization Dynamics during the Menstrual Cycle in Women with Congenital Long QT Syndrome.

Derick R. Peterson, P. Kudenchuk, T. Rea, 2022, Heart rhythm.

Use of Oral Contraceptives in Women with Congenital Long QT Syndrome.

P. Kudenchuk, T. Rea, D. Arking, 2021, Heart rhythm.

Outcome by Sex in Patients With Long QT Syndrome With an Implantable Cardioverter Defibrillator

P. Kudenchuk, T. Rea, D. Arking, 2020, Journal of the American Heart Association.

Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications

A. Moss, R. Gross, S. McNitt, 2018, Translational research : the journal of laboratory and clinical medicine.

Long QT Syndrome in Patients over 40 Years of Age: Increased Risk for LQTS‐Related Cardiac Events in Patients with Coronary Disease

A. Moss, W. Zareba, I. Goldenberg, 2008, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Phenotypic Variability in Caucasian and Japanese Patients with Matched LQT1 Mutations

A. Moss, W. Zareba, W. Shimizu, 2008, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Predictive value of device-derived activity level for short-term outcomes in MADIT-CRT.

Paul J. Wang, A. Moss, W. Zareba, 2017, Heart rhythm.

Differing effects of cardiac resynchronization therapy on long-term mortality in patient subgroups of MADIT-CRT defined by baseline conduction and 1-year post-treatment left ventricular remodeling.

A. Moss, W. Zareba, R. Krone, 2013, Heart rhythm.

Reduction of the Risk of Recurring Heart Failure Events With Cardiac Resynchronization Therapy MADIT-CRT (Multicenter Automatic Deﬁbrillator Implantation Trial with Cardiac Resynchronization Therapy) Automatic Implantation Trial with Cardiac Resynchronization

A. Moss, W. Zareba, I. Goldenberg, 2011 .

Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry

M. Link, H. Calkins, J. Towbin, 2016, Journal of cardiovascular electrophysiology.

Brain natriuretic peptide and the risk of ventricular tachyarrhythmias in mildly symptomatic heart failure patients enrolled in MADIT-CRT.

Paul J. Wang, A. Moss, W. Zareba, 2016, Heart rhythm.

Differences in Mode of Death between Men and Women Receiving Implantable Cardioverter Defibrillators or Cardiac Resynchronization Therapy in the MADIT Trials.

W. Zareba, S. McNitt, B. Polonsky, 2022, Heart rhythm.

Risk Stratiﬁcation for Primary Implantation of a Cardioverter-Deﬁbrillator in Patients With Ischemic Left Ventricular Dysfunction

A. Moss, W. Zareba, I. Goldenberg, 2008 .

Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.

W. Zareba, I. Goldenberg, S. McNitt, 2019, JACC. Clinical electrophysiology.

Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.

Paul J. Wang, A. Moss, W. Zareba, 2014, Journal of the American College of Cardiology.

Effectiveness of Cardiac Resynchronization Therapy with Defibrillator in At‐Risk Black and White Cardiac Patients

A. Moss, W. Zareba, I. Goldenberg, 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Early Procedure‐Related Adverse Events by Gender in MADIT‐CRT

A. Moss, W. Zareba, S. McNitt, 2014, Journal of cardiovascular electrophysiology.

Usefulness of Electrocardiographic Left Atrial Abnormality to Predict Response to Cardiac Resynchronization Therapy in Patients With Mild Heart Failure and Left Bundle Branch Block (a Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy).

S. Solomon, W. Zareba, P. Platonov, 2018, The American journal of cardiology.

REVERSE REMODELING AND THE RISK OF VENTRICULAR TACHYARRHYTHMIAS IN MADIT-CRT

Paul J. Wang, S. Solomon, A. Moss, 2011 .

Risk factors for ventricular tachyarrhythmic events in patients without left bundle branch block who receive cardiac resynchronization therapy

W. Zareba, I. Goldenberg, S. McNitt, 2020, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Applicability of the MADIT-CRT Response Score for Prediction of Long-Term Clinical and Arrhythmic Events by QRS Morphology.

W. Zareba, S. McNitt, M. Aktas, 2020, Circulation. Arrhythmia and electrophysiology.

Junctional AV ablation in patients with atrial fibrillation undergoing cardiac resynchronization therapy (JAVA-CRT): results of a multicenter randomized clinical trial pilot program

W. Zareba, C. Henrikson, J. Gorcsan, 2022, Journal of Interventional Cardiac Electrophysiology.

Response to letter regarding, "PR interval identifies clinical response in patients with non-left bundle branch block: a multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy sub-study" by Kutyifa et al.

A. Moss, W. Zareba, J. Daubert, 2014, Circulation. Arrhythmia and electrophysiology.

E. Kaufman, A. Moss, J. Towbin, 2012 .

Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients

Derick R. Peterson, S. Priori, A. Mazzanti, 2022, Frontiers in Cardiovascular Medicine.

Time-dependent beneﬁt of preventive cardiac resynchronization therapy after myocardial infarction

A. Moss, W. Zareba, M. Eldar, 2011 .

Clinical Impact, Safety, and Efficacy of Single‐ versus Dual‐Coil ICD Leads in MADIT‐CRT

A. Moss, W. Zareba, B. Merkely, 2013, Journal of cardiovascular electrophysiology.

Platelet ERK5 is a Redox Switch and Triggers Maladaptive Platelet Responses and Myocardial Infarct Expansion Running title: Cameron et al.; A New Platelet Target for Myocardial Infarction

Chakrabarti, J. Abe, S. McNitt, 2015 .

Stop-codon and C-terminus nonsense mutations are associated with lower risk of cardiac events in Long QT Syndrome Type 1 patients

A. Moss, W. Shimizu, A. Wilde, 2016 .

Scar burden assessed by Selvester QRS score predicts prognosis, not CRT clinical benefit in preventing heart failure event and death: A MADIT-CRT sub-study.

D. Strauss, W. Zareba, J. Daubert, 2016, Journal of electrocardiology.

Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval.

Wojciech Zareba, Jean-Philippe Couderc, Jean Xia, 2006, Heart rhythm.

Beta‐Blocker Efficacy in High‐Risk Patients with the Congenital Long‐QT Syndrome Types 1 and 2: Implications for Patient Management

A. Moss, W. Zareba, I. Goldenberg, 2010, Journal of cardiovascular electrophysiology.

Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

A. Moss, W. Zareba, I. Goldenberg, 2011, Journal of the American College of Cardiology.

Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.

A. Moss, W. Zareba, J. Daubert, 2006, Journal of the American College of Cardiology.

Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

A. Moss, W. Zareba, J. Daubert, 2013, Heart rhythm.

Renal Function Changes Following Left Ventricular Assist Device Implantation.

Leway Chen, S. McNitt, S. Sherazi, 2017, The American journal of cardiology.

Long QT syndrome and pregnancy.

E. Kaufman, S. Priori, A. Moss, 2007, Journal of the American College of Cardiology.

Effect of Novel Programming on Inappropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Very Low Ejection Fraction (from A MADIT-RIT).

Jagmeet P. Singh, W. Zareba, C. Schuger, 2022, The American journal of cardiology.

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

A. Moss, W. Zareba, I. Goldenberg, 2008, Journal of the American College of Cardiology.

Influence of Diabetes on Outcomes in Patients After Left Ventricular Assist Device Implantation

S. McNitt, S. Sherazi, V. Kutyifa, 2018 .

Myocardial performance is reduced immediately prior to ventricular ectopy.

K. Særmark, M. Haigney, S. McNitt, 2012, Heart rhythm.

Left atrial appendage exclusion with less invasive left ventricular assist device implantation

I. Goldenberg, S. McNitt, J. Alexis, 2022, Journal of cardiac surgery.

The role and outcomes of new supraventricular tachycardia among patients with mild heart failure

W. Zareba, I. Goldenberg, S. McNitt, 2020, Journal of cardiovascular electrophysiology.

Syncope in genotype-negative long QT syndrome family members.

A. Moss, A. Wilde, N. van Dijk, 2014, The American journal of cardiology.

Baseline Values and Sotalol‐Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug‐Induced Torsades de Pointes

Wojciech Zareba, Jean-Philippe Couderc, Martin Hinterseer, 2009, Journal of clinical pharmacology.

Risk of fatal arrhythmic events in long QT syndrome patients after syncope.

A. Moss, W. Zareba, I. Goldenberg, 2010, Journal of the American College of Cardiology.

Long QT syndrome in adults.

Andrew J. Sauer, E. Kaufman, S. Priori, 2007, Journal of the American College of Cardiology.

Risk of life-threatening cardiac events among patients with long QT syndrome and multiple mutations.

E. Kaufman, A. Moss, J. Towbin, 2013, Heart rhythm.

Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome.

E. Kaufman, A. Moss, J. Towbin, 2012, Heart rhythm.

Risk of Syncope in Family Members Who Are Genotype-Negative for a Family-Associated Long-QT Syndrome Mutation

E. Kaufman, A. Moss, J. Towbin, 2011, Circulation. Cardiovascular genetics.

Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome.

Derick R. Peterson, E. Kaufman, A. Moss, 2011, Heart rhythm.

Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome.

Derick R. Peterson, E. Kaufman, S. Priori, 2011, Journal of the American College of Cardiology.

Mutation-specific risk in two genetic forms of type 3 long QT syndrome.

A. Moss, P. Schwartz, W. Zareba, 2010, The American journal of cardiology.

Influence of diabetes mellitus on outcome in patients over 40 years of age with the long QT syndrome.

A. Moss, W. Zareba, I. Goldenberg, 2010, The American journal of cardiology.

Clinical implications for patients with long QT syndrome who experience a cardiac event during infancy.

E. Kaufman, S. Priori, A. Moss, 2009, Journal of the American College of Cardiology.

Risk of death in the long QT syndrome when a sibling has died.

E. Kaufman, S. Priori, A. Moss, 2008, Heart rhythm.

Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome

Derick R. Peterson, E. Kaufman, S. Priori, 2008, Circulation.

A quantitative assessment of T-wave morphology in LQT1, LQT2, and healthy individuals based on Holter recording technology.

Wojciech Zareba, Jean-Philippe Couderc, Arthur J Moss, 2008, Heart rhythm.

Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification.

A. Moss, W. Zareba, G. Vincent, 2006, Journal of the American College of Cardiology.

Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).

Paul J. Wang, S. Solomon, A. Moss, 2011, Journal of the American College of Cardiology.

The incidence and prognostic significance of new-onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy.

H. Huikuri, M. Messier, S. McNitt, 2011, Heart rhythm.

Effects of Statins on First and Recurrent Supraventricular Arrhythmias in Patients With Mild Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

A. Moss, W. Zareba, I. Goldenberg, 2015, The American journal of cardiology.

Catheter ablation of atrial fibrillation in the elderly: where do we stand?

W. Zareba, J. Daubert, Burr Hall, 2009, Cardiology journal.

Cardiac Resynchronization in Different Age Groups: A MADIT-CRT Long-Term Follow-Up Substudy.

A. Moss, W. Zareba, I. Goldenberg, 2016, Journal of cardiac failure.

Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study

Wojciech Zareba, Arthur J Moss, Mehmet K Aktas, 2016, Circulation. Arrhythmia and electrophysiology.

Characterization and predictors of first and subsequent inappropriate ICD therapy by heart rate ranges: Result of the MADIT-RIT efficacy analysis.

A. Moss, W. Zareba, J. Daubert, 2015, Heart rhythm.

Improved Outcome with Preventive Cardiac Resynchronization Therapy in the Elderly: A MADIT‐CRT Substudy

S. Solomon, A. Moss, W. Zareba, 2011, Journal of cardiovascular electrophysiology.

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT)

Paul J. Wang, S. Solomon, M. Gold, 2011, Circulation.

Outcomes associated with the high sensitivity cardiac troponin testing in patients presenting with non-cardiovascular disorders

J. Bisognano, S. McNitt, Shamroz Farooq, 2021, The American Journal of Emergency Medicine.

Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation.

A. Moss, W. Zareba, J. Daubert, 2006, Heart rhythm.

Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events: Implications for Mutation-Specific Response to &bgr;-Blocker Therapy in Type 1 Long-QT Syndrome

E. Kaufman, A. Moss, J. Towbin, 2012, Circulation.

Arrhythmogenic Cardiotoxicity Associated With Contemporary Treatments of Lymphoproliferative Disorders

I. Goldenberg, S. McNitt, S. Sherazi, 2023, Journal of the American Heart Association.

Association of previous cardiac surgery with outcomes in left ventricular assist device patients.

S. Prasad, Leway Chen, I. Goldenberg, 2020, Interactive cardiovascular and thoracic surgery.

Changes in Drug Utilization and Outcome With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.

A. Moss, W. Zareba, I. Goldenberg, 2015, Journal of cardiac failure.

Cumulative Burden of Atherosclerotic Risk Genotypes and the Age at Onset of a First Myocardial Infarction: A Case‐Only Carriership Approach

A. Moss, W. Zareba, I. Goldenberg, 2008, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Time-dependent risk of Fidelis lead failure.

Abrar H. Shah, A. Moss, W. Zareba, 2010, The American journal of cardiology.

Risk of Arrhythmic Events Following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy Using Continuous Implantable Cardiac Monitoring.

I. Goldenberg, S. McNitt, Peter A. Bleszynski, 2020, Heart rhythm.

Ranolazine Shortens Repolarization in Patients with Sustained Inward Sodium Current Due to Type‐3 Long‐QT Syndrome

A. Moss, W. Zareba, K. Schwarz, 2008, Journal of cardiovascular electrophysiology.

Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.

Arthur J Moss, Scott McNitt, S. Solomon, 2012, Journal of the American College of Cardiology.

Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results From the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT–CRT) Trial

S. Solomon, A. Moss, W. Zareba, 2014, Circulation.

Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results from the MADIT-CRT trial

Wojciech Zareba, Arthur J. Moss, Scott D. Solomon, 2014 .

Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT.

A. Moss, W. Zareba, I. Goldenberg, 2012, Journal of the American College of Cardiology.

Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)

S. Solomon, A. Moss, W. Zareba, 2011, Circulation.

Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.

Wojciech Zareba, Arthur J Moss, David T Huang, 2012, Journal of the American College of Cardiology.

Causes and Consequences of Heart Failure After Prophylactic Implantation of a Defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II

A. Moss, W. Zareba, D. Cannom, 2006, Circulation.

Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3)

A. Moss, C. Lowenstein, W. Zareba, 2018, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists.

E. Kaufman, A. Moss, W. Zareba, 2008, The American journal of cardiology.

Predictors of Spontaneous Reverse Remodeling in Mild Heart Failure Patients With Left Ventricular Dysfunction

S. Solomon, A. Moss, W. Zareba, 2014, Circulation. Heart failure.

Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction.

A. Moss, W. Zareba, M. Eldar, 2011, European heart journal.

Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator.

A. Moss, W. Zareba, M. Glikson, 2011, Heart rhythm.

Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

A. Moss, W. Zareba, I. Goldenberg, 2006, Journal of the American College of Cardiology.

Storms of ventricular tachycardia/fibrillation in MADIT II patients

A. Moss, W. Zareba, J. Daubert, 2005 .

The Impact of Nonsustained Ventricular Tachycardia on Reverse Remodeling, Heart Failure, and Treated Ventricular Tachyarrhythmias in MADIT‐CRT

A. Moss, W. Zareba, S. McNitt, 2014, Journal of cardiovascular electrophysiology.

Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation.

S. McNitt, S. Sherazi, V. Kutyifa, 2018, The Annals of thoracic surgery.

Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators.

Abrar H. Shah, W. Zareba, J. Daubert, 2010, Cardiology journal.

Efficacy of different beta-blockers in the treatment of long QT syndrome.

A. Moss, S. McNitt, D. Peterson, 2014, Journal of the American College of Cardiology.

Influence of Diabetes Mellitus on Inappropriate and Appropriate Implantable Cardioverter-Defibrillator Therapy and Mortality in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT) Trial

A. Moss, M. Shoda, W. Zareba, 2013, Circulation.

Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support.

A. Seidmann, I. Goldenberg, J. Bisognano, 2022, The American journal of cardiology.

Comparison of efficacy of implanted cardioverter-defibrillator in patients with versus without diabetes mellitus.

A. Moss, J. Cook, S. McNitt, 2005, The American journal of cardiology.

Risk Prediction in Women With Congenital Long QT Syndrome

P. Kudenchuk, T. Rea, C. Scott, 2021, Journal of the American Heart Association.

Comparison of age (<75 Years versus ≥75 Years) to risk of ventricular tachyarrhythmias and implantable cardioverter defibrillator shocks (from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

Paul J. Wang, A. Moss, W. Zareba, 2014, The American journal of cardiology.

Confirm Rx insertable cardiac monitor for primary atrial fibrillation detection in high‐risk heart failure patients (Confirm‐AF trial)

W. Zareba, J. Butler, Leway Chen, 2022, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Improved Survival Associated with Prophylactic Implantable Defibrillators in Elderly Patients with Prior Myocardial Infarction and Depressed Ventricular Function: A MADIT‐II Substudy

A. Moss, W. Zareba, J. Daubert, 2007, Journal of cardiovascular electrophysiology.

Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

Jagmeet P. Singh, J. Ruskin, A. Moss, 2005, Journal of the American College of Cardiology.

Clinical Implications of Complete Left-Sided Reverse Remodeling With Cardiac Resynchronization Therapy: A MADIT-CRT Substudy.

S. Solomon, A. Moss, W. Zareba, 2016, Journal of the American College of Cardiology.

The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudy.

A. Moss, W. Zareba, B. Merkely, 2014, Journal of cardiac failure.

One‐year follow‐up of the prospective registry of patients using the wearable defibrillator (WEARIT‐II Registry)

A. Moss, W. Zareba, I. Goldenberg, 2018, Pacing and clinical electrophysiology : PACE.

Multicenter Automatic Defibrillator Implantation Trial Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the

Wojciech Zareba, Jeffrey J. Goldberger, Iwona Cygankiewicz, 2011 .

The Effect of Intermittent Atrial Tachyarrhythmia on Heart Failure or Death inCardiac Resynchronization Therapy WithDefibrillator Versus Implantable Cardioverter-Defibrillator Patients

Paul J. Wang, A. Moss, W. Zareba, 2022 .

Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.

A. Moss, W. Zareba, J. Daubert, 2011, European heart journal.

Safety and Efficacy of Flecainide in Subjects with Long QT‐3 Syndrome (ΔKPQ Mutation): A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

A. Moss, W. Zareba, J. Daubert, 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Prognostic Significance of Heart Rate Variability Among Patients Treated With Cardiac Resynchronization Therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).

A. Moss, W. Zareba, J. Kautzner, 2015, JACC. Clinical electrophysiology.

Risk Factors for Recurrent Heart Failure Events in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT‐II)

A. Moss, W. Zareba, I. Goldenberg, 2010, Journal of cardiovascular electrophysiology.

Clinical presentation at first heart failure hospitalization does not predict recurrent heart failure admission

S. Solomon, A. Moss, B. Merkely, 2017, ESC heart failure.

The Effect of ICD Programming on Inappropriate and Appropriate ICD Therapies in Ischemic and Nonischemic Cardiomyopathy: The MADIT‐RIT Trial

A. Moss, W. Zareba, J. Kautzner, 2015, Journal of cardiovascular electrophysiology.

Association between myocardial substrate, implantable cardioverter defibrillator shocks and mortality in MADIT-CRT.

S. Solomon, A. Moss, W. Zareba, 2014, European heart journal.

Response to letter regarding article, "syncope in high-risk cardiomyopathy patients with implantable defibrillators: frequency, risk factors, mechanisms, and association with mortality: results from the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) s

A. Moss, M. Shoda, W. Zareba, 2014, Circulation.

Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Jørgen K. Kanters, E. Kaufman, A. Moss, 2016, Circulation.

Syncope in High-Risk Cardiomyopathy Patients With Implantable Defibrillators: Frequency, Risk Factors, Mechanisms, and Association With Mortality Results From the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT) Study

A. Moss, M. Shoda, W. Zareba, 2014, Circulation.

Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist device.

Leway Chen, S. McNitt, H. Massey, 2016, Heart rhythm.

Left Ventricular Pacing Threshold and Outcome in MADIT‐CRT

S. Solomon, A. Moss, W. Zareba, 2014, Journal of cardiovascular electrophysiology.

Effectiveness of Cardiac Resynchronization Therapy in Diabetic Patients with Ischemic and Nonischemic Cardiomyopathy

A. Moss, I. Goldenberg, S. McNitt, 2012, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Predictive value of global longitudinal strain by left ventricular ejection fraction

R. Lang, I. Goldenberg, B. Merkely, 2023, ESC heart failure.

Time dependence of life-threatening ventricular tachyarrhythmias after coronary revascularization in MADIT-CRT.

Paul J. Wang, A. Moss, W. Zareba, 2010, Heart rhythm.

Clinical course and outcome of patients enrolled in US and non-US centres in MADIT-CRT.

A. Moss, W. Zareba, M. Eldar, 2011, European heart journal.

Genetic biomarkers for the risk of seizures in long QT syndrome

A. Moss, W. Zareba, R. Gross, 2016, Neurology.

Right Ventricular Function, Pulmonary Pressure Estimation, and Clinical Outcomes in Cardiac Resynchronization Therapy

S. Solomon, M. Pfeffer, A. Moss, 2013, Circulation. Heart failure.

The Effect of Crt on Rv Function (rvf) Clinical Perspective on P 442

S. Solomon, M. Pfeffer, A. Moss, 2022 .

Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients.

A. Moss, W. Zareba, D. Rich, 2017, Journal of clinical lipidology.

Autonomic Dysfunction and New‐Onset Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction: A CARISMA Substudy

H. Huikuri, M. Messier, S. McNitt, 2010, Journal of cardiovascular electrophysiology.

ECG Marker of Adverse Electrical Remodeling Post-Myocardial Infarction Predicts Outcomes in MADIT II Study

Wojciech Zareba, Larisa G. Tereshchenko, Ronald D. Berger, 2012, PloS one.

Prognostic value of average T-wave alternans and QT variability for cardiac events in MADIT-II patients.

Pablo Laguna, Violeta Monasterio, Wojciech Zareba, 2013, Journal of electrocardiology.

Cardiac Resynchronization Therapy and Risk of Recurrent Hospitalizations in Patients Without Left Bundle Branch Block

S. Solomon, W. Zareba, I. Goldenberg, 2020, Circulation. Heart failure.

Dyssynchrony, Contractile Function, and Response to Cardiac Resynchronization Therapy

H. Uno, S. Solomon, M. Pfeffer, 2011, Circulation. Heart failure.

Atrial Fibrillation in Long QT Syndrome by Genotype.

W. Zareba, P. Platonov, S. McNitt, 2019, Circulation. Arrhythmia and electrophysiology.

Arrhythmia and Survival Outcomes among Black and White Patients with a Primary Prevention Defibrillator

W. Zareba, O. Wazni, I. Goldenberg, 2023, medRxiv.

Arrhythmia Burden in Patients with Indolent Lymphoma

J. Friedberg, I. Goldenberg, S. McNitt, 2020, Blood.

Quantitative T‐wave morphology assessment from surface ECG is linked with cardiac events risk in genotype‐positive KCNH2 mutation carriers with normal QTc values

W. Zareba, P. Platonov, S. McNitt, 2019, Journal of cardiovascular electrophysiology.

T-wave morphology abnormalities in benign, potent, and arrhythmogenic I(kr) inhibition.

Wojciech Zareba, Jean-Philippe Couderc, Arthur J Moss, 2011, Heart rhythm.

P‐wave Morphology Is Associated with Echocardiographic Response to Cardiac Resynchronization Therapy in MADIT‐CRT Patients

S. Solomon, A. Moss, W. Zareba, 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Abnormal P‐Wave Morphology Is a Predictor of Atrial Fibrillation Development and Cardiac Death in MADIT II Patients

A. Moss, W. Zareba, P. Platonov, 2010, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)

A. Moss, W. Zareba, I. Goldenberg, 2015, Circulation.

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.

A. Moss, A. Baranchuk, W. Zareba, 2018, Journal of the American College of Cardiology.

Reduction in life-threatening ventricular tachyarrhythmias in statin-treated patients with nonischemic cardiomyopathy enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy).

Paul J. Wang, A. Moss, M. Eldar, 2012, Journal of the American College of Cardiology.

Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2

E. Kaufman, A. Moss, J. Towbin, 2011, Circulation.

Primary prevention with the implantable cardioverter-defibrillator in high-risk long-QT syndrome patients

A. Moss, W. Zareba, I. Goldenberg, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Impaired T‐Amplitude Adaptation to Heart Rate Characterizes IKr Inhibition in the Congenital and Acquired Forms of the Long QT Syndrome

A. Moss, W. Zareba, J. Couderc, 2007, Journal of cardiovascular electrophysiology.

Ventricular Electrical Delay Measured From Body Surface ECGs Is Associated With Cardiac Resynchronization Therapy Response in Left Bundle Branch Block Patients From the MADIT-CRT Trial (Multicenter Automatic Defibrillator Implantation-Cardiac Resynchronization Therapy)

Wojciech Zareba, Filip Plesinger, Josef Halamek, 2018, Circulation. Arrhythmia and electrophysiology.

Age and the Risk of Ventricular Tachyarrhythmia in Patients With an Implantable Cardioverter-Defibrillator.

W. Zareba, I. Goldenberg, S. McNitt, 2022, JACC. Clinical electrophysiology.

Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.

A. Moss, W. Zareba, I. Goldenberg, 2018, Heart rhythm.

Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator

W. Zareba, O. Wazni, I. Goldenberg, 2023, Circulation.

Left Atrial Volume and the Benefit of Cardiac Resynchronization Therapy in the MADIT-CRT Trial

S. Solomon, A. Moss, W. Zareba, 2014, Circulation. Heart failure.

Outcomes Associated with Introduction of the 5th Generation High-Sensitivity Cardiac Troponin in Patients Presenting with Cardiovascular Disorders.

I. Goldenberg, J. Bisognano, S. McNitt, 2022, The Journal of emergency medicine.

Sex-Differences in Arrhythmic Burden with the Wearable Cardioverter Defibrillator.

A. Russo, B. Assmus, S. McNitt, 2020, Heart rhythm.

Outcomes of gastrointestinal bleeding in patients with left ventricular assist devices: a tertiary care experience

V. Kaul, Leway Chen, S. McNitt, 2020, Endoscopy International Open.

Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.

W. Zareba, B. Merkely, A. Kosztin, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Risk of Mortality for Ventricular Arrhythmia in Ambulatory LVAD Patients

David T Huang, Sushma Koneru, Mohan Rao, 2012, Journal of cardiovascular electrophysiology.

Intraoperative Ventricular Tachycardia Ablation During Left Ventricular Assist Device Implantation in High-Risk Heart Failure Patients.

I. Goldenberg, S. McNitt, M. Aktas, 2022, Circulation. Arrhythmia and electrophysiology.

Design and characteristics of the prophylactic intra‐operative ventricular arrhythmia ablation in high‐risk LVAD candidates (PIVATAL) trial

G. Couper, W. Zareba, F. Marchlinski, 2023, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Predictors of Atrial Fibrillation During Long‐Term Implantable Cardiac Monitoring Following Cryptogenic Stroke

I. Goldenberg, S. McNitt, S. Rosero, 2020, Journal of the American Heart Association.

Implantable Cardioverter Defibrillators and Survival in Continuous-Flow Left Ventricular Assist Device Patients

Leway Chen, S. McNitt, H. Massey, 2017, ASAIO journal.

Predictors and Risk of Ventricular Tachyarrhythmias or Death in Black and White Cardiac Patients: A MADIT-CRT Trial Substudy.

A. Moss, W. Zareba, M. Glikson, 2016, JACC. Clinical electrophysiology.

Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40.

Abrar H. Shah, W. Zareba, K. Schwarz, 2015, Cardiology journal.

Primary prevention implantable cardioverter defibrillator in cardiac resynchronization therapy recipients with advanced chronic kidney disease

W. Zareba, C. Schuger, I. Goldenberg, 2023, Frontiers in cardiovascular medicine.

Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome.

W. Zareba, A. Wilde, I. Goldenberg, 2023, JAMA cardiology.

Response to Letter Regarding Article, “Predictors of Response to Cardiac Resynchronization Therapy in The Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)”

A. Moss, W. Zareba, J. Goldberger, 2012 .

In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models.

Jørgen K. Kanters, A. Moss, W. Zareba, 2012, Journal of the American College of Cardiology.

Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT ( Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy )

Paul J. Wang, A. Moss, M. Eldar, 2012 .

T-wave alternans predicts ICD discharge in MADIT II patients with elevated resting heart rate

Pablo Laguna, Violeta Monasterio, Juan Pablo Martínez, 2013, Computing in Cardiology 2013.

Clinical predictors of survival in patients treated with therapeutic hypothermia following cardiac arrest.

J. Daubert, S. McNitt, M. Aktas, 2010, Resuscitation.

Arrhythmic and Mortality Outcomes Among Ischemic Versus Nonischemic Cardiomyopathy Patients Receiving Primary Implantable Cardioverter-Defibrillator Therapy.

W. Zareba, J. Daubert, I. Goldenberg, 2021, JACC. Clinical electrophysiology.

Genetic variant annotation scores in congenital long QT syndrome

P. Kudenchuk, D. Arking, W. Zareba, 2023, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death

A. Moss, H. Klein, S. McNitt, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Mutations in Cytoplasmic Loops of the KCNQ1 Channel and the Risk of Life-Threatening Events: Implications for Mutation-Specific Response to &bgr;-Blocker Therapy in Type 1 Long-QT Syndrome

Derick R. Peterson, E. Kaufman, A. Moss, 2012, Circulation.

Long QT Syndrome in African‐Americans

A. Moss, W. Zareba, I. Goldenberg, 2010, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Paul J. Wang, S. Solomon, A. Moss, 2015, European heart journal.

Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment.

M. Link, W. Zareba, N. Estes, 2014, Journal of the American College of Cardiology.

Reduction in inappropriate therapy and mortality through ICD programming.

A. Moss, M. Shoda, W. Zareba, 2012, The New England journal of medicine.

Effect of Carvedilol vs Metoprolol on Atrial and Ventricular Arrhythmias Among Implantable Cardioverter-Defibrillator Recipients.

W. Zareba, I. Goldenberg, S. McNitt, 2023, JACC. Clinical electrophysiology.

Novel ICD Programming and Inappropriate ICD Therapy in CRT-D Versus ICD Patients: A MADIT-RIT Sub-Study

A. Moss, W. Zareba, J. Daubert, 2016, Circulation. Arrhythmia and electrophysiology.

Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)

A. Moss, W. Zareba, I. Goldenberg, 2015, Circulation.

A. Moss, M. Shoda, W. Zareba, 2014, Circulation.

Syncope in High-Risk Cardiomyopathy Patients with Implantable Defibrillators: Frequency, Risk Factors, Mechanisms and Association with Mortality: Results from the MADIT-RIT Study

M. Shoda, W. Zareba, S. McNitt, 2013 .

Long-Term Clinical Course of Patients After Termination of Ventricular Tachyarrhythmia by an Implanted Defibrillator

A. Moss, W. Zareba, J. Daubert, 2004, Circulation.

Long QT syndrome in adults.

Derick R. Peterson, Andrew J. Sauer, E. Kaufman, 2007, Journal of the American College of Cardiology.

Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study.

Derick R. Peterson, Jørgen K. Kanters, E. Kaufman, 2016, Circulation.

clinical aspects of type 3 long-Qt syndrome an international Multicenter study